Insider Transactions in Q1 2024 at Avrobio, Inc. (AVRO)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 05
2024
|
Azadeh Golipour Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,232
-17.96%
|
$12,232
$1.2 P/Share
|
|
Feb 05
2024
|
Steven Avruch Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,812
-32.93%
|
$10,812
$1.2 P/Share
|
|
Feb 05
2024
|
Erik Ostrowski Interim CEO, President and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,099
-30.91%
|
$13,099
$1.2 P/Share
|
|
Feb 05
2024
|
Essra Ridha Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,953
-51.63%
|
$16,953
$1.2 P/Share
|
|
Feb 01
2024
|
Azadeh Golipour Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
37,334
+35.41%
|
-
|
|
Feb 01
2024
|
Steven Avruch Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
32,834
+50.0%
|
-
|
|
Feb 01
2024
|
Erik Ostrowski Interim CEO, President and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
40,084
+48.61%
|
-
|
|
Feb 01
2024
|
Essra Ridha Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
32,834
+50.0%
|
-
|